Mitobridge

Risk score

57
Large logo of Mitobridge

Headquarters

Flag of United States of AmericaUnited States of America

Mitobridge is uncovering and creating new medications that enhance mitochondrial functions. Expanding on the emerging scientific discoveries connecting mitochondrial irregularities with disease pathologies, we are advancing original methods for the treatment of illnesses with significant medical needs that are not currently met. Our approach involves demonstrating the feasibility in rare illnesses and then broadening into more prevalent conditions. Mitobridge has constructed a robust team with proficiency in progressing pioneering therapeutics into clinical trials.